NVAX

Novavax (NVAX)

Novavax Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NVAX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/05/10	21 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NVAX	Novavax Inc
2024/05/10	21 : 02	IH Market News	Novavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More News	NASDAQ:NVAX	Novavax Inc
2024/05/10	15 : 15	PR Newswire (US)	Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	NASDAQ:NVAX	Novavax Inc
2024/05/10	15 : 00	PR Newswire (US)	Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines	NASDAQ:NVAX	Novavax Inc
2024/05/09	05 : 53	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/08	06 : 21	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/08	03 : 43	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NVAX	Novavax Inc
2024/05/07	22 : 25	PR Newswire (US)	Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024	NASDAQ:NVAX	Novavax Inc
2024/05/07	20 : 44	IH Market News	Tesla’s April Sales Down 18% in China, Amazon’s Multi-Billion Dollar Cloud Expansion in Singapore, and More News	NASDAQ:NVAX	Novavax Inc
2024/05/07	05 : 43	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/06	19 : 22	GlobeNewswire Inc.	Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting	NASDAQ:NVAX	Novavax Inc
2024/04/15	19 : 00	GlobeNewswire Inc.	Shah Capital nominates two highly qualified independent director candidates for Novavax	NASDAQ:NVAX	Novavax Inc
2024/04/01	21 : 00	PR Newswire (US)	Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024	NASDAQ:NVAX	Novavax Inc
2024/03/06	09 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/03/01	06 : 02	PR Newswire (US)	Novavax to Participate in TD Cowen's 44th Annual Health Care Conference	NASDAQ:NVAX	Novavax Inc
2024/02/28	22 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/02/28	22 : 00	PR Newswire (US)	Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	NASDAQ:NVAX	Novavax Inc
2024/02/28	21 : 30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NVAX	Novavax Inc
2024/02/23	22 : 03	IH Market News	Goldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and More	NASDAQ:NVAX	Novavax Inc
2024/02/22	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/02/22	20 : 00	PR Newswire (US)	Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement	NASDAQ:NVAX	Novavax Inc
2024/02/20	23 : 25	PR Newswire (US)	Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024	NASDAQ:NVAX	Novavax Inc
2024/01/31	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/01/26	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/01/08	23 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/01/03	23 : 25	PR Newswire (US)	Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:NVAX	Novavax Inc
2023/12/19	07 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2023/12/19	07 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2023/12/19	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc